BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, April 17, 2026
Home
»
Authors
»
James Etheridge
Articles by James Etheridge
Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia
June 18, 2008
By
James Etheridge
SiRNAsense Picks Polyplus's in Vivo Delivery Platform
June 18, 2008
By
James Etheridge
Transgene's TG4010 Vaccine Meets Phase IIb Trial Endpoint
June 11, 2008
By
James Etheridge
Edmond de Rothschild Closes 150 Million BioDiscovery Fund
June 4, 2008
By
James Etheridge
Innate Launches Preclinical Work on First Antibody in Novo Deal
June 4, 2008
By
James Etheridge
BioAlliance Buys Rights to NovaDel's Ondansetron
May 28, 2008
By
James Etheridge
Trophos Launches Phase II Trial of TRO19622 in Liver Disease
May 21, 2008
By
James Etheridge
NicOx Antihypertensive Taken Into Phase I Trial by Merck
May 14, 2008
By
James Etheridge
Polyplus-transfection Unveils New siRNA Technology
April 30, 2008
By
James Etheridge
Sanofi-Aventis Stops Developing Two Genfit Drug Candidates
April 9, 2008
By
James Etheridge
Previous
1
2
3
4
5
6
7
8
9
10
11
…
90
91
Next
